PharVision Advisers’s Alexandria Real Estate Equities ARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,525
Closed -$210K 695
2025
Q3
$210K Buy
+2,525
New +$202K 0.12% 474

Other funds holding ARE

PharVision Advisers's ARE Position: Q4 2025 in Review

PharVision Advisers sold out of Alexandria Real Estate Equities (ARE) in Q4 2025, closing a stake of 2,525 shares — an estimated $210K sold.

PharVision Advisers first reported a position in ARE in Q3 2025 and held it in 1 quarter. The position peaked at $210K in Q3 2025. 597 funds tracked by Wall St. Rank hold ARE as of Q4 2025.

  • PharVision Advisers reported no remaining Alexandria Real Estate Equities position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 2,525 Alexandria Real Estate Equities shares in Q4 2025, an estimated $210K.
  • PharVision Advisers first reported a position in Alexandria Real Estate Equities in Q3 2025 and held it in 1 quarter.
  • PharVision Advisers's Alexandria Real Estate Equities position peaked at $210K in Q3 2025.
  • 597 funds tracked by Wall St. Rank held Alexandria Real Estate Equities as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.